Singapur - angleščina - HSA (Health Sciences Authority)

ziwell medical (s) pte ltd - levofloxacin hemihydrate 512.46mg eqv levofloxacin - tablet, film coated - levofloxacin hemihydrate 512.46mg eqv levofloxacin 500mg

Singapur - angleščina - HSA (Health Sciences Authority)

ziwell medical (s) pte ltd - levofloxacin hemihydrate 256.23mg eqv levofloxacin - tablet, film coated - levofloxacin hemihydrate 256.23mg eqv levofloxacin 250.0mg

Armenija - angleščina - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

rottendorf pharma gmbh - levofloxacin (levofloxacin hemihydrate) - tablets film-coated - 250mg

Kenija - angleščina - Pharmacy and Poisons Board

hetero labs limited 7-2-a2 hetero corporate industrial estates sanath - levofloxacin hemihydrate - film-coated tablet - each film coated tablet contains256.24 mg of… - antibacterials for systemic use: fluoroquinolones

Kenija - angleščina - Pharmacy and Poisons Board

surgilinks ltd c/o stallion laboratories pvt. ltd p.o box 14461 - 00800, nairobi - levofloxacin hemihydrate usp & ornidazole - film-coated tablet - levofloxacin hemihydrate usp eq. to levofloxacin… - antibacterials for systemic use: fluoroquinolones

Kenija - angleščina - Pharmacy and Poisons Board

denk pharma gmbh & co. kg prinzregentenstr. 79, 81675 münchen germany - levofloxacin hemihydrate - film-coated tablet - 250 mg levofloxacin, equivalent to 256.23 mg… - antibacterials for systemic use: fluoroquinolones

Kenija - angleščina - Pharmacy and Poisons Board

shelys pharmaceuticals ltd. plot no. 696 new bagamoyo road mwenge p.o. box - levofloxacin - film-coated tablet - levofloxacin hemihydrate equivalent to… - antibacterials for systemic use: fluoroquinolones

Združene države Amerike - angleščina - NLM (National Library of Medicine)

preferred pharmaceuticals inc. - levofloxacin (unii: 6gnt3y5lmf) (levofloxacin anhydrous - unii:rix4e89y14) - levofloxacin anhydrous 750 mg - levofloxacin tablets are indicated in adult patients for the treatment of nosocomial pneumonia due to methicillin-susceptible staphylococcus aureus, pseudomonas aeruginosa, serratia marcescens, escherichia coli,klebsiella pneumoniae, haemophilus influenzae, or streptococcus pneumoniae. adjunctive therapy should be used as clinically indicated. where pseudomonas aeruginosa is a documented or presumptive pathogen, combination therapy with an anti-pseudomonal β-lactam is recommended [see clinical studies (14.1)]. levofloxacin tablets are indicated in adult patients for the treatment of community-acquired pneumonia due to methicillin-susceptible staphylococcus aureus, streptococcus pneumoniae (including  multi-drug-resistant streptococcus pneumoniae [mdrsp]), haemophilus influenzae, haemophilus parainfluenzae, klebsiella pneumoniae, moraxella catarrhalis, chlamydophila pneumoniae, legionella pneumophila, or mycoplasma pneumoniae [see dosage and administration (2.1) and clinical studies (14.2)]. mdrsp isolat

Združene države Amerike - angleščina - NLM (National Library of Medicine)

blenheim pharmacal, inc. - levofloxacin (unii: 6gnt3y5lmf) (levofloxacin anhydrous - unii:rix4e89y14) - levofloxacin anhydrous 500 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of levofloxacin and other antibacterial drugs, levofloxacin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. levofloxacin tablets are indicated for the treatment of adults (≥18 years of age) with mild, moderate, and severe infections caused by susceptible isolates of the designated microorganisms in the conditions listed in this section. culture and susceptibility testing appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing the infection and to determine their susceptibility to levofloxacin [see microbiology (12.4

Irska - angleščina - HPRA (Health Products Regulatory Authority)

rowex ltd - levofloxacin - film coated tablet - 250 milligram